NCT07052734View on ClinicalTrials.gov

Miti-gene Recurrence Score in HR+/HER2- Chinese Breast Cancer Patients

CompletedOBSERVATIONAL
Enrollment

2,843

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

June 18, 2025

Study Completion Date

June 18, 2025

Conditions
Breast Cancer
Trial Locations (1)

510060

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT07052734 - Miti-gene Recurrence Score in HR+/HER2- Chinese Breast Cancer Patients | Biotech Hunter | Biotech Hunter